This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Musculoskeletal pain in Parkinson's disease

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Musculoskeletal pain in Parkinson's disease (PD)

  • most common PD pain symptom is pain arising from joints, muscles, and the axial skeleton (1)
  • can present as a prodromal symptom
  • been shown that severity of pain is significantly correlated with the severity of motor complications of PD (2)
  • prevalence of musculoskeletal pain ranges from 40% to 75% in those patients with PD experiencing pain (2)
    • musculoskeletal problems are more common in patients with PD than in elderly without PD
  • PD disease process causes:
    • camptocormia (abnormal forward trunk flexion) and
    • Pisa syndrome (abnormal lateral trunk flexion) accompanied by muscular rigidity
  • leads to abnormal posture and stress on ligaments, facet joints, and soft tissue resulting in pain
  • presentation of musculoskeletal pain presentation is similar to patients without PD; however, subtle postural abnormalities need to be explored clinically as this pain is not amenable to traditional pain relief medication and needs physiotherapeutic interventions and rehabilitation (1)
  • most frequent presentations are
    • low back pain
      • prevalence of low back pain is 50% higher in PD than age-matched controls (1)
      • risk factors for lower back pain include older age, higher depression score, and PD-related factors, including rigidity and poor posture (2)
      • stated that patients with PD that have lower back pain have longer disease durations and higher pain intensities, compared to those without pain (2)
    • shoulder pain
      • unilateral musculoskeletal pain, especially in shoulder arm distribution, is highly specific of PD and may predate rigidity and bradykinesia (1)
    • arthralgias
      • patients with PD that have co-morbid osteoarthritis reported specific pain characteristics (2)
        • more likely to have paraesthesia- and akathisia-related pain, and less likely to have aching pain, compared to patients with PD without osteoarthritis
    • general muscle aches and cramps
  • non-pharmacological management:
    • multidisciplinary approach to care involving specialist nurses, physiotherapy, occupational therapy, and social prescribing is highly recommended
    • a balanced diet
      • can address pains related to constipation, decreased bone density, and low mood
      • food affects levodopa absorption resulting in steady state levels of dopamine, which may alleviate some symptoms
    • early recognition and treatment of depression also helps in pain modulation
    • exercise therapy, involving correct posture and muscle strengthening, improves musculoskeletal pain and quality of life
    • acupuncture and alternative therapies such as mindfulness or meditation may be of value in motivated patients
  • specific management (1):
    • suggested first-line therapy options include:
      • non-steroidal anti inflammatory drugs (NSAIDs)
      • physiotherapy
      • occupational therapy
    • suggested second-line therapy options include:
      • low-dose opioids
      • tricyclic antidepressants

Reference:

  • Khan AZ et al. Pain syndromes in Parkinson’s disease: an update for general practice. BJGP 2024; 74 (739): 90-92.
  • Tai YC, Lin CH. An overview of pain in Parkinson's disease. Clin Park Relat Disord. 2019 Nov 28;2:1-8.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.